EGFR mutations and human papillomavirus in lung cancer

Lung Cancer

Volumn 78, Issue 2, 2012, Pages 144-147

  Kato, Takuya ^a   Koriyama, Chihaya ^a   Khan, Noureen ^a   Samukawa, Takuya ^a   Yanagi, Masakazu ^a   Hamada, Tsutomu ^a   Yokomakura, Naoya ^a   Otsuka, Takeshi ^a   Inoue, Hiromasa ^a   Sato, Masami ^a   Natsugoe, Shoji ^a   Akiba, Suminori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Epidermal growth factor receptor; Gefitinib; Human papillomavirus; Mutation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; VIRUS DNA;

AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; EXON; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; JAPANESE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; WART VIRUS;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; VIRAL LOAD;

EID: 84867399072     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.08.011     Document Type: Article

References (28)

1. Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983, 80:3812-3815.
2. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007, 90:476-477.
3. Klein F., Amin Kotb W.F., Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65:13-18.
4. Aguayo F., Castillo A., Koriyama C., Higashi M., Itoh T., Capetillo M., et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 2007, 97:85-91.
5. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001, 61:2799-2803.
6. Baba M., Castillo A., Koriyama C., Yanagi M., Matsumoto H., Natsugoe S., et al. Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 2010, 23:1085-1092.
7. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
8. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
9. Mitsudomi T., Kosaka T., Yatabe Y. Biological and clinical implications of EGFR mutations in lung cancer. Int J Clin Oncol 2006, 11:190-198.
10. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998, 153:1731-1739.
11. Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002, 40:886-891.
12. Sharma S.V., Bell D.W., Settleman J., Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007, 7:169-181.
13. Sugio K., Uramoto H., Ono K., Oyama T., Hanagiri T., Sugaya M., et al. Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking. Br J Cancer 2006, 94:896-903.
14. Wu H.H., Wu J.Y., Cheng Y.W., Chen C.Y., Lee M.C., Goan Y.G., et al. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. Clin Cancer Res 2010, 16:5200-5210.
15. Arias-Pulido H., Joste N., Chavez A., Muller C.Y., Dai D., Smith H.O., et al. Absence of epidermal growth factor receptor mutations in cervical cancer. Int J Gynecol Cancer 2008, 18:749-757.
16. Na I.I., Kang H.J., Cho S.Y., Koh J.S., Lee J.K., Lee B.C., et al. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur J Cancer 2007, 43:520-526.
17. Mitsudomi T., Yatabe Y. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci 2007, 98:1817-1824.
18. Tang X., Shigematsu H., Bekele B.N., Roth J.A., Minna J.D., Hong W.K., et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005, 65:7568-7572.
19. Ciotti M., Giuliani L., Ambrogi V., Ronci C., Benedetto A., Mineo T.C., et al. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 2006, 16:183-189.
20. Chen Y.C., Chen J.H., Richard K., Chen P.Y., Christiani D.C. Lung adenocarcinoma and human papillomavirus infection. Cancer 2004, 101:1428-1436.
21. Sihto H., Puputti M., Pulli L., Tynninen O., Koskinen W., Aaltonen L.M., et al. Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors. J Mol Med (Berl) 2005, 83:976-983.
22. Yousem S.A., Ohori N.P., Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992, 69:693-697.
23. Henken F.E., Banerjee N.S., Snijders P.J., Meijer C.J., De-Castro Arce J., Rosl F., et al. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer 2011, 10:71.
24. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008, 68:307-313.
25. Masuda A., Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002, 21:6884-6897.
26. Smith E.M., Ritchie J.M., Summersgill K.F., Klussmann J.P., Lee J.H., Wang D., et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004, 108:766-772.
27. Gazdar A.F., Shigematsu H., Herz J., Minna J.D. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?. Trends Mol Med 2004, 10:481-486.
28. Hosokawa S., Toyooka S., Fujiwara Y., Tokumo M., Soh J., Takigawa N., et al. Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer. Lung Cancer 2009, 66:107-113.